SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNLX - NanoLogix, Incorporated -- Ignore unavailable to you. Want to Upgrade?

To: kphone who wrote (57)4/5/2013 10:58:55 PM
From: Dwayne Hines  Respond to of 78
 
Website has been updated announcing the following:

April 05, 2013:
NanoLogix plans to begin marketing this summer of their new N-Assay Multiwell Diagnostic test. The N-Assay is a machine-readable test that will be available in an assortment of size configurations for detection and identification of a variety of bacteria. Tests to date have provided consistent results in as little as 30 minutes with both high sensitivity and specificity.
___________



To: kphone who wrote (57)4/11/2014 3:39:16 PM
From: Dwayne Hines  Respond to of 78
 
Update -
April 11, 2014: 
Saudi Arabia FDA listing.  NanoLogix was informed today that Nasaem AlJazira has received notification their application for Saudi Arabian MDNR (Medical Device National Registration) listing for NanoLogix products has been approved. Saudi Arabia FDA approval is pending.



To: kphone who wrote (57)10/21/2014 4:58:21 PM
From: Dwayne Hines  Respond to of 78
 
Mentioned in Washington Post - washingtonpost.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News